Evolocumab
Brand name: Repatha Sureclick
Rank #40 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$460.5M
Total Cost
528,560
Total Claims
$460.5M
Total Cost
14,741
Prescribers
$871
Cost per Claim
54,056
Beneficiaries
779,525
30-Day Fills
$31K
Avg Cost/Provider
36
Avg Claims/Provider
Share of Medicare Part D Spending
0.17%
of total Medicare Part D spending
$460.5M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $460.5M total
🔎 Data Overview
Ranked #40 out of 500 drugs tracked by total cost. Evolocumab represents a significant portion of Medicare drug spending.
Average cost of $8,520 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Evolocumab
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | James Trippi | Cardiology | Indianapolis, IN | 1,246 | $1.7M |
| 2 | Janice Mcalister | Nurse Practitioner | Atlanta, GA | 1,262 | $1.7M |
| 3 | Scott Merryman | Family Practice | Columbus, OH | 1,525 | $1.3M |
| 4 | James O'keefe | Cardiology | Kansas City, MO | 742 | $901K |
| 5 | Jaesoo Pak | Internal Medicine | Cerritos, CA | 1,307 | $899K |
| 6 | Afshine Emrani | Cardiology | Tarzana, CA | 1,150 | $856K |
| 7 | Diane Sobkowicz | Cardiology | Auburn, CA | 604 | $844K |
| 8 | Weston Whittington | Cardiology | Fort Collins, CO | 629 | $791K |
| 9 | Jeffrey Boone | Internal Medicine | Greenwood Village, CO | 774 | $757K |
| 10 | Diane Osborn | Nurse Practitioner | Portland, OR | 541 | $713K |
| 11 | Patrick Moriarty | Internal Medicine | Kansas City, KS | 927 | $711K |
| 12 | Uri Ben-Zur | Cardiology | Tarzana, CA | 849 | $698K |
| 13 | John Isaac | Cardiology | Houston, TX | 920 | $695K |
| 14 | Nancy Dagefoerde | Nurse Practitioner | Rockford, IL | 436 | $691K |
| 15 | Durga Madala | Cardiology | San Jose, CA | 694 | $687K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 37 | Tafamidis (Vyndamax) | $511.1M | 20,589 |
| 38 | Fluticasone/Vilanterol (Breo Ellipta) | $493.0M | 909,837 |
| 39 | Tiotropium Bromide (Spiriva Handihaler) | $478.1M | 673,800 |
| 40 | Evolocumab (Repatha Sureclick) | $460.5M | 528,560 |
| 41 | Acalabrutinib Maleate (Calquence) | $457.0M | 31,890 |
| 42 | Atorvastatin Calcium (Atorvastatin Calcium) | $444.6M | 30,263,929 |
| 43 | Osimertinib Mesylate (Tagrisso) | $436.5M | 25,273 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology